These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17173664)

  • 1. The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD).
    Sagvolden T
    Behav Brain Funct; 2006 Dec; 2():41. PubMed ID: 17173664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. l-Amphetamine improves poor sustained attention while d-amphetamine reduces overactivity and impulsiveness as well as improves sustained attention in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD).
    Sagvolden T; Xu T
    Behav Brain Funct; 2008 Jan; 4():3. PubMed ID: 18215285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impulsiveness, overactivity, and poorer sustained attention improve by chronic treatment with low doses of l-amphetamine in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD).
    Sagvolden T
    Behav Brain Funct; 2011 Mar; 7():6. PubMed ID: 21450079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and genetic evidence for a novel animal model of Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive Subtype.
    Sagvolden T; Dasbanerjee T; Zhang-James Y; Middleton F; Faraone S
    Behav Brain Funct; 2008 Dec; 4():56. PubMed ID: 19046438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of postsynapse adrenergic α2A receptor improves attention/cognition performance in an animal model of attention deficit hyperactivity disorder.
    Kawaura K; Karasawa J; Chaki S; Hikichi H
    Behav Brain Res; 2014 Aug; 270():349-56. PubMed ID: 24882610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.
    Russell VA
    Behav Brain Res; 2002 Mar; 130(1-2):191-6. PubMed ID: 11864734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.
    Russell V; Allie S; Wiggins T
    Behav Brain Res; 2000 Dec; 117(1-2):69-74. PubMed ID: 11099759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes.
    Sagvolden T; Johansen EB; Aase H; Russell VA
    Behav Brain Sci; 2005 Jun; 28(3):397-419; discussion 419-68. PubMed ID: 16209748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of SHR, WKY and Wistar rats in different behavioural animal models: effect of dopamine D1 and alpha2 agonists.
    Langen B; Dost R
    Atten Defic Hyperact Disord; 2011 Mar; 3(1):1-12. PubMed ID: 21432613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine-stimulated release of [3H]norepinephrine is reduced in the hippocampus of an animal model of attention-deficit/hyperactivity disorder, the spontaneously hypertensive rat.
    Sterley TL; Howells FM; Russell VA
    Brain Res; 2014 Jul; 1572():1-10. PubMed ID: 24833064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased glutamate-stimulated norepinephrine release from prefrontal cortex slices of spontaneously hypertensive rats.
    Russell VA; Wiggins TM
    Metab Brain Dis; 2000 Dec; 15(4):297-304. PubMed ID: 11383554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired visuospatial divided attention in the spontaneously hypertensive rat.
    Jentsch JD
    Behav Brain Res; 2005 Feb; 157(2):323-30. PubMed ID: 15639183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for reduced tonic levels of GABA in the hippocampus of an animal model of ADHD, the spontaneously hypertensive rat.
    Sterley TL; Howells FM; Russell VA
    Brain Res; 2013 Dec; 1541():52-60. PubMed ID: 24161405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanfacine extended release: a novel treatment for attention-deficit/hyperactivity disorder in children and adolescents.
    Faraone SV; McBurnett K; Sallee FR; Steeber J; López FA
    Clin Ther; 2013 Nov; 35(11):1778-93. PubMed ID: 24139092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Spatial Memory Deficit and Hyperactivity in Dopamine Transporter Knockout Rats
    Kurzina N; Belskaya A; Gromova A; Ignashchenkova A; Gainetdinov RR; Volnova A
    Front Psychiatry; 2022; 13():851296. PubMed ID: 35401264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute and sub-chronic administrations of guanfacine on catecholaminergic transmissions in the orbitofrontal cortex.
    Okada M; Fukuyama K; Kawano Y; Shiroyama T; Suzuki D; Ueda Y
    Neuropharmacology; 2019 Sep; 156():107547. PubMed ID: 30802458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mesocortical dopaminergic system cannot explain hyperactivity in an animal model of attention deficit hyperactivity disorder (ADHD)- Spontaneously hypertensive rats (SHR).
    Gungor Aydin A; Adiguzel E
    Lab Anim Res; 2023 Sep; 39(1):20. PubMed ID: 37710339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine regulates frontocorticostriatal dopamine transporter density and improves attention and cognitive deficits in an animal model of attention deficit hyperactivity disorder.
    Pandolfo P; Machado NJ; Köfalvi A; Takahashi RN; Cunha RA
    Eur Neuropsychopharmacol; 2013 Apr; 23(4):317-28. PubMed ID: 22561003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oroxylin A improves attention deficit hyperactivity disorder-like behaviors in the spontaneously hypertensive rat and inhibits reuptake of dopamine in vitro.
    Yoon SY; dela Peña I; Kim SM; Woo TS; Shin CY; Son KH; Park H; Lee YS; Ryu JH; Jin M; Kim KM; Cheong JH
    Arch Pharm Res; 2013 Jan; 36(1):134-40. PubMed ID: 23371806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-methyl-D-aspartate receptor subunit dysfunction at hippocampal glutamatergic synapses in an animal model of attention-deficit/hyperactivity disorder.
    Jensen V; Rinholm JE; Johansen TJ; Medin T; Storm-Mathisen J; Sagvolden T; Hvalby O; Bergersen LH
    Neuroscience; 2009 Jan; 158(1):353-64. PubMed ID: 18571865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.